Lab‑Leak Claims Reset U.S. Biosecurity Priorities

A high‑profile WMD report arguing COVID‑19 likely came from a Chinese lab and that the work may have been tied to military research pushes the U.S. to shift resources from cooperative public‑health research toward intelligence collection, treaty enforcement, and hard biosafety rules. That reorientation would change funding, oversight, and diplomatic posture toward China and global lab governance. — If adopted, this reframing could restructure U.S. biodefense budgets, politicize scientific collaboration with China, and drive demands for enforceable international lab inspections.